Selected research
Industry Research
Tick-borne Encephalitis Vaccine Industry Research Report 2026
Market perspective
The global Tick-borne Encephalitis Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tick-borne Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tick-borne Encephalitis Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tick-borne Encephalitis Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tick-borne Encephalitis Vaccine include Pfizer, Superdrug Health, Sonic HealthPlus, Encephalitis and Cochrane Collaboration, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tick-borne Encephalitis Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tick-borne Encephalitis Vaccine Market by Company
Pfizer
Superdrug Health
Sonic HealthPlus
Encephalitis
Cochrane Collaboration
Tick-borne Encephalitis Vaccine Segment by Type
European TBE Virus
Siberian TBE Virus
Far Eastern TBE Virus
Tick-borne Encephalitis Vaccine Segment by Application
Adult Vaccines
Pediatric Vaccines
Traveler Vaccines
Tick-borne Encephalitis Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tick-borne Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tick-borne Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tick-borne Encephalitis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tick-borne Encephalitis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tick-borne Encephalitis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tick-borne Encephalitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- European TBE Virus
- Siberian TBE Virus
- Far Eastern TBE Virus
Applications
- Adult Vaccines
- Pediatric Vaccines
- Traveler Vaccines
Companies covered
- Pfizer
- Superdrug Health
- Sonic HealthPlus
- Encephalitis
- Cochrane Collaboration
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tick-borne Encephalitis Vaccine Market Size (2021-2032)
- 2.2.2 Global Tick-borne Encephalitis Vaccine Sales (2021-2032)
- 2.2.3 Global Tick-borne Encephalitis Vaccine Market Average Price (2021-2032)
- 2.3 Tick-borne Encephalitis Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 European TBE Virus
- 2.3.3 Siberian TBE Virus
- 2.3.4 Far Eastern TBE Virus
- 2.4 Tick-borne Encephalitis Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult Vaccines
- 2.4.3 Pediatric Vaccines
- 2.4.4 Traveler Vaccines
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tick-borne Encephalitis Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tick-borne Encephalitis Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tick-borne Encephalitis Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Tick-borne Encephalitis Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Tick-borne Encephalitis Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tick-borne Encephalitis Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tick-borne Encephalitis Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Tick-borne Encephalitis Vaccine, Established Date
- 3.9 Global Tick-borne Encephalitis Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Tick-borne Encephalitis Vaccine Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Superdrug Health
- 4.2.1 Superdrug Health Company Information
- 4.2.2 Superdrug Health Business Overview
- 4.2.3 Superdrug Health Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Superdrug Health Tick-borne Encephalitis Vaccine Product Portfolio
- 4.2.5 Superdrug Health Recent Developments
- 4.3 Sonic HealthPlus
- 4.3.1 Sonic HealthPlus Company Information
- 4.3.2 Sonic HealthPlus Business Overview
- 4.3.3 Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Portfolio
- 4.3.5 Sonic HealthPlus Recent Developments
- 4.4 Encephalitis
- 4.4.1 Encephalitis Company Information
- 4.4.2 Encephalitis Business Overview
- 4.4.3 Encephalitis Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Encephalitis Tick-borne Encephalitis Vaccine Product Portfolio
- 4.4.5 Encephalitis Recent Developments
- 4.5 Cochrane Collaboration
- 4.5.1 Cochrane Collaboration Company Information
- 4.5.2 Cochrane Collaboration Business Overview
- 4.5.3 Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Portfolio
- 4.5.5 Cochrane Collaboration Recent Developments
5 Global Tick-borne Encephalitis Vaccine Market Scenario by Region
- 5.1 Global Tick-borne Encephalitis Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tick-borne Encephalitis Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Tick-borne Encephalitis Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Tick-borne Encephalitis Vaccine Sales by Region: 2027-2032
- 5.3 Global Tick-borne Encephalitis Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Tick-borne Encephalitis Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Tick-borne Encephalitis Vaccine Revenue by Region: 2027-2032
- 5.4 North America Tick-borne Encephalitis Vaccine Market Facts & Figures by Country
- 5.4.1 North America Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tick-borne Encephalitis Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Tick-borne Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tick-borne Encephalitis Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tick-borne Encephalitis Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Tick-borne Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Tick-borne Encephalitis Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tick-borne Encephalitis Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tick-borne Encephalitis Vaccine Market Facts & Figures by Country
- 5.7.1 South America Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tick-borne Encephalitis Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Tick-borne Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Tick-borne Encephalitis Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tick-borne Encephalitis Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Tick-borne Encephalitis Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Tick-borne Encephalitis Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Tick-borne Encephalitis Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Tick-borne Encephalitis Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tick-borne Encephalitis Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Tick-borne Encephalitis Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tick-borne Encephalitis Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Tick-borne Encephalitis Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Tick-borne Encephalitis Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Tick-borne Encephalitis Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tick-borne Encephalitis Vaccine Value Chain Analysis
- 8.1.1 Tick-borne Encephalitis Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tick-borne Encephalitis Vaccine Production Mode & Process
- 8.2 Tick-borne Encephalitis Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tick-borne Encephalitis Vaccine Distributors
- 8.2.3 Tick-borne Encephalitis Vaccine Customers
9 Global Tick-borne Encephalitis Vaccine Analyzing Market Dynamics
- 9.1 Tick-borne Encephalitis Vaccine Industry Trends
- 9.2 Tick-borne Encephalitis Vaccine Industry Drivers
- 9.3 Tick-borne Encephalitis Vaccine Industry Opportunities and Challenges
- 9.4 Tick-borne Encephalitis Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst